AI Science Tracker
EN

Automatic Transcranial Sonography-Based Classification of Parkinson's Disease Using a Novel Dual-Channel CNXV2-DANet.

Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Research Institute of Smart Ageing, The Hong Kong Polytechnic University, Hong Kong SAR, China.; Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. · 31 Aug 2024 · medicine

Discovery

Automatic Transcranial Sonography-Based Classification of Parkinson's Disease Using a Novel Dual-Channel CNXV2-DANet.

Source check: Source checked. Not independent scientific confirmation.

Finding: Retrospective study of 588 subjects with transcranial sonography images classified for Parkinson's disease by a dual-channel CNXV2-DANet, evaluated on an independent test split. AI role: Dual-channel CNXV2-DANet deep-learning classifier. The article appeared in Bioengineering (Basel, Switzerland).

Technology: Dual-channel CNXV2-DANet deep-learning classifier

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Dual-channel CNXV2-DANet deep-learning classifier
Test and result
Retrospective study of 588 subjects with transcranial sonography images classified for Parkinson's disease by a dual-channel CNXV2-DANet, evaluated on an independent test split.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://mdpi-res.com/d_attachment/bioengineering/bioengineering-11-00889/article_deploy/bioengineering-11-00889.pdf · https://pubmed.ncbi.nlm.nih.gov/39329631/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.